Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Motivation og Neurotransmittere i Roere

15. september 2026 opdateret af: Poznan University of Physical Education

Psykobiologiske Korrelationer af Præstationsmotivation og Neurotransmitterrespons på Træning hos Elite-Roere

The goal of this observational study is to learn how motivation and body chemistry are linked during and after intense exercise in national-level rowers.

The main questions this study aims to answer are:

Do athletes with higher motivation show different changes in brain chemicals after exercise? How do hormone and neurotransmitter levels change during recovery after exercise?

Participants will:

Complete a motivation questionnaire called the Inventory of Achievement Motivation (LMI) before the exercise test.

Perform a 6000-meter rowing test on an indoor rowing machine. Have blood samples taken three times: before exercise, immediately after exercise, and 1 hour after exercise.

Researchers will measure blood levels of testosterone, cortisol, serotonin, dopamine, beta-endorphin, anandamide (AEA), and 2-arachidonoylglycerol (2-AG).

This study will help researchers understand how motivation and body chemistry work together to influence performance and recovery in highly trained athletes.

Studieoversigt

Status

Afsluttet

Betingelser

Detaljeret beskrivelse

This study explores how motivation and body chemistry are connected during and after intense physical exercise in national-level rowers. Researchers want to understand how psychological factors, such as motivation to achieve goals, relate to changes in hormones and brain chemicals that occur with exercise and recovery.

Before the exercise test, participants will complete a motivation questionnaire called the Inventory of Achievement Motivation (LMI). This questionnaire helps identify how strongly a person is driven to perform, overcome challenges, and reach success.

After the questionnaire, each participant will complete a 6000-meter rowing test on an indoor rowing machine. This test is designed to produce a high level of physical effort similar to competition conditions. Blood samples will be taken three times: before the test, immediately after the test, and one hour after recovery.

The blood samples will be used to measure levels of several hormones and neurotransmitters, including testosterone, cortisol, serotonin, dopamine, beta-endorphin, anandamide (AEA), and 2-arachidonoylglycerol (2-AG). These substances are involved in stress response, motivation, reward, and recovery.

Researchers will compare the results from the motivation questionnaire with changes in hormone and neurotransmitter levels. The goal is to find out whether more motivated athletes show different chemical responses to exercise and recovery.

Findings from this study may improve understanding of how the mind and body interact during intense training. This knowledge could help athletes and coaches develop better ways to support motivation, performance, and recovery in high-level sports.

Undersøgelsestype

Observationel

Tilmelding (Faktiske)

24

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Greater Poland Voivodeship
      • Poznan, Greater Poland Voivodeship, Polen, 61-871
        • Poznań University of Physical Education

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 25 år (Voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Han

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

All participants were recruited and tested at the Central Sports Centre - Olympic Preparation Center (COS OPO) in Wałcz, Poland, during a national team training camp under standardized conditions.

Beskrivelse

Inclusion Criteria:

National-level male rowers Age between 18 and 25 years Minimum of 3 years of systematic rowing training Regular training load (at least 10 sessions per week during the competitive season) Good general health and medical clearance for maximal exercise testing

Exclusion Criteria:

Current illness, injury, or infection Use of medications or dietary supplements that could affect hormone or neurotransmitter levels Smoking or use of psychoactive substances Inadequate sleep or food intake before testing Refusal or inability to provide informed consent

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Observationsmodeller: COHORT
  • Tidsperspektiver: RETROSPECTIVE

Kohorter og interventioner

Gruppe / kohorte
Intervention / Behandling
Rowers

The study includes 24 national-level male rowers. All participants are healthy, highly trained athletes with at least 3 years of systematic rowing experience and regular intensive training.

Participants perform a 6000-meter rowing test on an indoor ergometer at maximal effort to simulate race conditions and induce physiological fatigue.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Changes in serum Cortisol levels
Tidsramme: Before exercise, immediately after, and 1 hour after recovery

Measurement of Cortisol serum concentrations (ng/mL).

Before exercise, immediately after, and 1 hour after recovery
Changes in serum Testosterone levels
Tidsramme: Before exercise, immediately after, and 1 hour after recovery

Measurement of Testosterone serum concentrations (ng/mL).

Before exercise, immediately after, and 1 hour after recovery
Changes in serum Dopamin levels
Tidsramme: Before exercise, immediately after, and 1 hour after recovery

Measurement of Dopamin serum concentrations (ng/mL).

Before exercise, immediately after, and 1 hour after recovery
Changes in serum Serotonin levels
Tidsramme: Before exercise, immediately after, and 1 hour after recovery

Measurement of Serotonin serum concentrations (ng/mL).

Before exercise, immediately after, and 1 hour after recovery
Changes in serum Beta-endorphin levels
Tidsramme: Before exercise, immediately after, and 1 hour after recovery

Measurement of Beta-endorphin serum concentrations (ng/mL).

Before exercise, immediately after, and 1 hour after recovery
Changes in serum anandamide (AEA) levels
Tidsramme: Before exercise, immediately after, and 1 hour after recovery

Measurement of anandamide (AEA) serum concentrations (ng/mL).

Before exercise, immediately after, and 1 hour after recovery
Changes in serum 2-arachidonoylglycerol (2-AG)) levels
Tidsramme: Before exercise, immediately after, and 1 hour after recovery

Measurement of 2-arachidonoylglycerol (2-AG) serum concentrations (ng/mL).

Before exercise, immediately after, and 1 hour after recovery

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Changes in Testosterone-to-cortisol ratio (T:C)
Tidsramme: Before exercise, immediately after, and 1 hour after recovery

Ratio calculated from serum testosterone and cortisol concentrations (ng/mL), used as an indicator of anabolic-catabolic balance.

Before exercise, immediately after, and 1 hour after recovery
Changes in TSerotonin-to-dopamine ratio (S:D)
Tidsramme: Before exercise, immediately after, and 1 hour after recovery

Ratio of serum serotonin to dopamine concentrations (ng/mL), reflecting neurochemical balance related to motivation and fatigue.

Before exercise, immediately after, and 1 hour after recovery
Achievement Motivation (LMI score)
Tidsramme: Before exercise (baseline)

Assessment of achievement motivation using the Inventory of Achievement Motivation (LMI). The questionnaire evaluates multiple dimensions of motivation, such as persistence, confidence in success, goal setting, and compensatory effort. Total and subscale scores are analyzed to identify individual motivational profiles.

Before exercise (baseline)

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. november 2023

Primær færdiggørelse (Faktiske)

28. november 2023

Studieafslutning (Faktiske)

2. december 2023

Datoer for studieregistrering

Først indsendt

14. november 2025

Først indsendt, der opfyldte QC-kriterier

14. november 2025

Først opslået (Faktiske)

19. november 2025

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

18. september 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

15. september 2026

Sidst verificeret

1. november 2025

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • LMI60002023

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

IPD-planbeskrivelse

Individual participant data (IPD) will not be shared. Data will be used only for internal analysis and dissemination in scientific publications in aggregate form, in accordance with ethical approval.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner